slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 32,791-32,820
Pages 1,371
Rows per page 30
Component
32,791-32,820 of 41,127
02
23andMe | Investor Presentation Deck | 39 slides23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations 1 hit
25
The chart uses a swimmer plot format to visualize patient-level treatment duration, dose escalation, and response status.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
27
The slide uses a Gantt-style visualization to map clinical trial milestones (First Efficacy Assessment, 6-mo PFS/OS, 12-mo PFS/OS) against calendar quarters from 2023 to 2026.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
The chart demonstrates superior efficacy of 23ME-00610 over anti-PD1 in stimulating IFNy across multiple cancer types.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The table uses checkmarks and crosses to indicate the presence or absence of specific therapeutic attributes across four different drug programs.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
21
Includes a dog (Penelope) as 'Chief Morale Officer' as a lighthearted team member entry.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations 1 hit
12
The chart highlights a positive trend in US comps, reaching 2% in Q3 2023.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · The BreakthroughLoop · Cost Of Inaction1 hit
08
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · EvidenceLoop · Voice Of Customer1 hit
11
Includes product branding and dosing regimen details.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · EvidenceLoop · Voice Of Customer1 hit
13
Includes disclaimer regarding patent litigation and definition of R12M.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · EvidenceLoop · Voice Of Customer1 hit
18
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
27
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution1 hit
29
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution1 hit
02
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
26
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
02
argenx SE | Investor Conference Presentation Deck | 27 slidesargenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Humble Origins1 hit
02
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Humble Origins1 hit
25
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations 1 hit
26
AstraZeneca | Investor Conference Presentation Deck | 26 slidesAstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
Page number 02 in top right corner.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
Slide 03 of the deck.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Includes two line charts showing PK and PD profiles across different dosage levels.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide outlines a 12-week open-label study with a specific focus on treatment-resistant depression (TRD).ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide uses a line chart to show the change in MADRS scores over 12 weeks for three different dosages.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Includes trial objectives and timeline markers for both parts.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
39
The competitor is represented by the French flag icon.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
118
The slide uses a pyramid to visualize wealth segments and their respective counts.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
122
Zegna | Investor Day Presentation Deck | 150 slidesZegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
123
Includes company branding and date.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
124
Includes company logo, title, date, and a disclaimer about the preliminary nature of the data.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit